CDK Inhibitors approved by PBAC but cost is still an issue 20 April 2018

Options
Giovanna_BCNA
Giovanna_BCNA Member Posts: 1,839 ✭
edited April 2018 in Community news and events

CDK Inhibitors approved by Pharmaceutical Benefits Advisory Committee (PBAC) but cost is still an issue

See the link below for further information
https://www.bcna.org.au/news/2018/04/cdk-inhibitors-approved-by-pbac-but-costs-still-an-issue/

Tagged:

Categories